-
Je něco špatně v tomto záznamu ?
Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptake
Priwitzerova M, Nie G, Sheftel AD, Pospisilova D, Divoky V, Ponka P.
Jazyk angličtina Země Spojené státy americké
Grantová podpora
NR7799
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Část
Zdroj
NLK
Free Medical Journals
od 1946 do Před 1 rokem
Freely Accessible Science Journals
od 1946 do Před 1 rokem
Open Access Digital Library
od 1946-01-01
Open Access Digital Library
od 1946-01-01
Elsevier Open Access Journals
od 1946-01-01 do 2023-06-22
ROAD: Directory of Open Access Scholarly Resources
Elsevier Open Archive Journals
od 1946 do Před 1 rokem
- MeSH
- bodová mutace MeSH
- CHO buňky MeSH
- financování organizované MeSH
- fluorescenční protilátková technika MeSH
- hypochromní anemie genetika MeSH
- křečci praví MeSH
- lidé MeSH
- proteiny přenášející kationty genetika metabolismus MeSH
- proteiny vázající železo genetika metabolismus MeSH
- transfekce MeSH
- western blotting MeSH
- železo metabolismus MeSH
- zvířata MeSH
- Check Tag
- křečci praví MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
We have previously described a case of severe hypochromic microcytic anemia caused by a homozygous mutation in the divalent metal transporter 1 (DMT1 1285G > C). This mutation encodes for an amino acid substitution (E399D) and causes preferential skipping of exon 12 during processing of the DMT1 mRNA. To examine the functional consequences of this mutation, full-length DMT1 transcript with the patient's point mutation or a DMT1 transcript with exon 12 deleted was expressed in Chinese hamster ovary (CHO) cells. Our results demonstrate that the E399D substitution has no effect on protein expression and function. In contrast, deletion of exon 12 led to a decreased expression of the protein and disruption of its subcellular localization and iron uptake activity. We hypothesize that the residual protein in hematopoietic cells represents the functional E399D DMT1 variant, but because of its quantitative reduction, the iron uptake activity of DMT1 in the patient's erythroid cells is severely suppressed.
- 000
- 02917naa 2200445 a 4500
- 001
- bmc07507957
- 003
- CZ-PrNML
- 005
- 20130830104112.0
- 008
- 080821s2005 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Horváthová, Monika, $d 1978- $7 ntk2011644397
- 245 10
- $a Functional consequences of the human DMT1 (SLC11A2) mutation on protein expression and iron uptake / $c Priwitzerova M, Nie G, Sheftel AD, Pospisilova D, Divoky V, Ponka P.
- 314 __
- $a Department of Biology, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.
- 520 9_
- $a We have previously described a case of severe hypochromic microcytic anemia caused by a homozygous mutation in the divalent metal transporter 1 (DMT1 1285G > C). This mutation encodes for an amino acid substitution (E399D) and causes preferential skipping of exon 12 during processing of the DMT1 mRNA. To examine the functional consequences of this mutation, full-length DMT1 transcript with the patient's point mutation or a DMT1 transcript with exon 12 deleted was expressed in Chinese hamster ovary (CHO) cells. Our results demonstrate that the E399D substitution has no effect on protein expression and function. In contrast, deletion of exon 12 led to a decreased expression of the protein and disruption of its subcellular localization and iron uptake activity. We hypothesize that the residual protein in hematopoietic cells represents the functional E399D DMT1 variant, but because of its quantitative reduction, the iron uptake activity of DMT1 in the patient's erythroid cells is severely suppressed.
- 650 _2
- $a proteiny přenášející kationty $x genetika $x metabolismus $7 D027682
- 650 _2
- $a železo $x metabolismus $7 D007501
- 650 _2
- $a proteiny vázající železo $x genetika $x metabolismus $7 D033862
- 650 _2
- $a hypochromní anemie $x genetika $7 D000747
- 650 _2
- $a western blotting $7 D015153
- 650 _2
- $a CHO buňky $7 D016466
- 650 _2
- $a křečci praví $7 D006224
- 650 _2
- $a fluorescenční protilátková technika $7 D005455
- 650 _2
- $a bodová mutace $7 D017354
- 650 _2
- $a transfekce $7 D014162
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Nie, Guangjun
- 700 1_
- $a Sheftel, Alex D.
- 700 1_
- $a Pospíšilová, Dagmar $7 xx0052603
- 700 1_
- $a Divoký, Vladimír $7 xx0018902
- 700 1_
- $a Ponka, Prem
- 773 0_
- $w MED00000807 $t Blood $g Roč. 106, č. 12 (2005), s. 3985-3987 $x 0006-4971
- 910 __
- $a ABA008 $b B 405 $y 9
- 990 __
- $a 20080721085927 $b ABA008
- 991 __
- $a 20130830104556 $b ABA008
- 999 __
- $a ok $b bmc $g 623561 $s 475994
- BAS __
- $a 3
- BMC __
- $a 2005 $b 106 $c 12 $d 3985-3987 $i 0006-4971 $m Blood $x MED00000807
- GRA __
- $a NR7799 $p MZ0
- LZP __
- $a 2008-Doreen